EVOLUTION® Duodenal Stent for Duodenal or Gastric Outlet Obstruction Caused by Malignant Neoplasms
NCT ID: NCT00991614
Last Updated: 2012-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
110 participants
OBSERVATIONAL
2009-12-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evolution® Biliary Stent System-Fully Covered
NCT02104076
EUS-GE vs ES for Palliation of Gastric Outlet Obstruction
NCT03259763
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
NCT00004910
Covered Self-expandable Metal Stents for Palliation of Malignant Biliary Strictures: Evaluation of a New Type of Stent
NCT01457105
Comparison of Duodenal Stenting vs Transpyloric and Duodenal Stenting for Malignant Obstruction
NCT03125148
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EVOLUTION® Duodenal Stent
EVOLUTION® Duodenal Stent
EVOLUTION® Duodenal Stent
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EVOLUTION® Duodenal Stent
EVOLUTION® Duodenal Stent
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Group Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Professor Guido Costamagna, MD
Role: PRINCIPAL_INVESTIGATOR
U.O. Endoscopia Digestiva Chirurgica
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westmead Hospital
Sydney, , Australia
Hopital Saint-Luc / CHUM
Montreal, Quebec, Canada
Institution for Clinical and Experimental Medicine
Prague, , Czechia
IRCCS Instituto Clinico Humanitas
Milan, , Italy
U.O. Endoscopia Digestiva Chirurgica
Rome, , Italy
Erasmus MC University Medical Center
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tringali A, Didden P, Repici A, Spaander M, Bourke MJ, Williams SJ, Spicak J, Drastich P, Mutignani M, Perri V, Roy A, Johnston K, Costamagna G. Endoscopic treatment of malignant gastric and duodenal strictures: a prospective, multicenter study. Gastrointest Endosc. 2014 Jan;79(1):66-75. doi: 10.1016/j.gie.2013.06.032. Epub 2013 Aug 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.